Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2026-01-13 @ 7:58 PM
Study NCT ID:
NCT02498600
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2015-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-26
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-14
First Submit QC Date:
None
Study First Post Date:
2015-07-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-05-27
Results First Submit QC Date:
None
Results First Post Date:
2020-09-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-16
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED